Because MS is a known risk factor for NAFLD, most guidelines suggest that these individuals have their levels of aminotransferases evaluated, especially ALT, as it correlates to liver fat content [18,20,24]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.